Catalyst Wire Dossier Catalyst Wire Dossier

TMC310911

· Tibotec Pharmaceuticals, Ireland
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TMC310911, covering 2010-04-28 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients [Phase 2]

See pricing